top of page

SANDOSTATIN LAR FOR INJECTION 30 mg

Product details

Registration number: SIN11638P

Classification: Prescription Only

Active ingredients: OCTREOTIDE ACETATE 33.6MG EQV OCTREOTIDE

Strength: 30 mg/vial

Dosage form: INJECTION

Route: INTRAMUSCULAR

Registrant: NOVARTIS (SINGAPORE) PTE LTD

ATC code: H01CB02

HSA approval date: 20 August 2001

Manufacturer(s):

  • Novartis Pharmaceutical Manufacturing GmbH
  • Abbott Biologicals B.V. (Vehicle solution)

Manufacturing country/countries: AUSTRIA; NETHERLANDS

What are the HSA registration number and classification for SANDOSTATIN LAR FOR INJECTION 30 mg?

According to the HSA dataset updated 7 August 2026:

Registration number: SIN11638P

Classification: Prescription Only

Source for this answer

What active ingredients and strength are recorded for SANDOSTATIN LAR FOR INJECTION 30 mg?

According to the HSA dataset updated 7 August 2026:

Active ingredients: OCTREOTIDE ACETATE 33.6MG EQV OCTREOTIDE

Strength: 30 mg/vial

Ingredients and strengths are listed separately as recorded by HSA; their positions do not establish a one-to-one match. This is not a dosing instruction.

Source for this answer

What dosage form and route are recorded for SANDOSTATIN LAR FOR INJECTION 30 mg?

According to the HSA dataset updated 7 August 2026:

Dosage form: INJECTION

Route: INTRAMUSCULAR

Source for this answer

Who is the recorded registrant for SANDOSTATIN LAR FOR INJECTION 30 mg?

According to the HSA dataset updated 7 August 2026:

Registrant: NOVARTIS (SINGAPORE) PTE LTD

Source for this answer

Which manufacturers and countries are listed for SANDOSTATIN LAR FOR INJECTION 30 mg?

According to the HSA dataset updated 7 August 2026:

Manufacturer(s):

  • Novartis Pharmaceutical Manufacturing GmbH
  • Abbott Biologicals B.V. (Vehicle solution)

Manufacturing country/countries: AUSTRIA; NETHERLANDS

Source for this answer

Where can I look up SANDOSTATIN LAR FOR INJECTION 30 mg in the HSA register?

Open HSA’s therapeutic product register and search for registration number SIN11638P or the exact product name SANDOSTATIN LAR FOR INJECTION 30 mg. The general register link does not preselect this product.

Source for this answer

What are the source dates for this SANDOSTATIN LAR FOR INJECTION 30 mg record?

This record is from HSA’s List of Registered Therapeutic Products on data.gov.sg. Dataset update: 7 August 2026. Retrieval date: 13 November 2026.

The dataset date is a snapshot date, not a separate current-register check for every product. Later direct checks are recorded separately.

Source for this answer

Has this SANDOSTATIN LAR FOR INJECTION 30 mg record had a separate HSA register check?

No separate current-register check is recorded for this product. Its presence in the imported dataset does not establish its current registration status.

Search the HSA register using SIN11638P for the latest record.

Source for this answer

Sources and dates

HSA dataset: 2026. Updated: 13 November 2026.

Factual product information only; no dosing, treatment or suitability advice.

Updated and reviewed by: Dr Joel Lim MBChB UK (PG Dip Dermatology), Resident Physician.

bottom of page